2018, Número 5
<< Anterior Siguiente >>
Ann Hepatol 2018; 17 (5)
Serum Electrolyte Levels and Outcomes in Patients Hospitalized with Hepatic Encephalopathy
Alsaad AA, Stancampiano FF, Palmer WC, Henry AM, Jackson JK, Heckman MG, Diehl NN, Keaveny AP
Idioma: Ingles.
Referencias bibliográficas: 20
Paginas: 836-842
Archivo PDF: 147.67 Kb.
RESUMEN
Sin resumen.
REFERENCIAS (EN ESTE ARTÍCULO)
Aldworth G. Hepatic encephalopathy. Ann Clin Biochem 2017; 54: 416.
Weiss N, Jalan R, Thabut D. Understanding hepatic encephalopathy. Intensive Care Med 2018; 44: 231-4.
Wijdicks EF. Hepatic Encephalopathy. N Engl J Med 2016; 375: 1660-70.
Tapper EB, Jiang ZG, Patwardhan VR. Refining the ammonia hypothesis: a physiology-driven approach to the treatment of hepatic encephalopathy. Mayo Clin Proc 2015; 90: 646-58.
Tamaoki S, Suzuki H, Okada M, Fukui N, Isobe M, Saito T. Development of an experimental rat model of hyperammonemic encephalopathy and evaluation of the effects of rifaximin. Eur J Pharmacol 2016; 779: 168-76.
Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, Weissenborn K, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology 2014; 60: 715-35.
Han KH. Mechanisms of the effects of acidosis and hypokalemia on renal ammonia metabolism. Electrolyte Blood Press 2011; 9: 45-9.
Iwasa M, Sugimoto R, Mifuji-Moroka R, Hara N, Yoshikawa K, Tanaka H, Eguchi A, et al. Factors contributing to the development of overt encephalopathy in liver cirrhosis patients. Metab Brain Dis 2016; 31: 1151-6.
Pantham G, Post A, Venkat D, Einstadter D, Mullen KD. A New Look at Precipitants of Overt Hepatic Encephalopathy in Cirrhosis. Dig Dis Sci 2017; 62: 2166-73.
Fichet J, Mercier E, Genee O, Garot D, Legras A, Dequin PF, Perrotin D. Prognosis and 1-year mortality of intensive care unit patients with severe hepatic encephalopathy. J Crit Care 2009; 24: 364-70.
Bajaj JS, O’Leary JG, Tandon P, Wong F, Garcia-Tsao G, Kamath PS, Maliakkal B, et al. Hepatic Encephalopathy Is Associated With Mortality in Patients With Cirrhosis Independent of Other Extrahepatic Organ Failures. Clin Gastroenterol Hepatol 2017; 15: 565-74 e564.
Rassameehiran S, Mankongpaisarnrung C, Sutamtewagul G, Klomjit S, Rakvit A. Predictor of 90-Day Readmission Rate for Hepatic Encephalopathy. South Med J 2016; 109: 365-9.
Cordoba J, Garcia-Martinez R, Simon-Talero M. Hyponatremic and hepatic encephalopathies: similarities, differences and coexistence. Metab Brain Dis 2010; 25: 73-80.
Montagnese S, Angeli P, Craxi A. Between reality and the guidelines: A survey on perception, diagnosis and manage ment of hepatic encephalopathy in 201 Italian specialist centres. Dig Liver Dis 2017; 49: 828-30.
Guevara M, Baccaro ME, Rios J, Martin-Llahi M, Uriz J, Ruiz del Arbol L, Planas R, et al. Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration. Liver Int 2010; 30: 1137-42.
Guevara M, Gines P. [Hyponatremia in liver cirrhosis: pathogenesis and treatment]. Endocrinol Nutr 2010; 57(Suppl. 2): 15-21.
Categorical Data Analysis With SAS and SPSS Applications (Book). Sci-Tech News 2003; 57: 66.
Harrell FE. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York: Springer; 2001; xxii, p. 568.
Guevara M, Baccaro ME, Torre A, Gomez-Anson B, Rios J, Torres F, Rami L, et al. Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis. Am J Gastroenterol 2009; 104: 1382-9.
Qureshi MO, Khokhar N, Saleem A, Niazi TK. Correlation of hyponatremia with hepatic encephalopathy and severity of liver disease. J Coll Physicians Surg Pak 2014; 24: 135-7.
Texto completo
Cómo citar este artículo